Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy

Buyuksimsek M., Ogul A., Mirilli C., PAYDAŞ S.

EUROPEAN JOURNAL OF BREAST HEALTH, cilt.16, sa.4, ss.229-234, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5152/ejbh.2020.5556
  • Dergi Adı: EUROPEAN JOURNAL OF BREAST HEALTH
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.229-234
  • Anahtar Kelimeler: Breast cancer, dNLR, MHR, NLR, PNI, PROGNOSTIC NUTRITIONAL INDEX, SURGICAL ADJUVANT BREAST, LYMPHOCYTE RATIO, NEUTROPHIL, SURVIVAL, THERAPY, RECOMMENDATIONS, BIOMARKERS, RECEPTORS, CARCINOMA
  • Çukurova Üniversitesi Adresli: Evet

Özet

Objective: Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in some patients with breast cancer (BC). The aim of this study is to explore the predictive value of some inflammatory markers including neutrophil-to-lymphocyte ratio (NLR), derived neutrophilto-lymphocyte ratio (dNLR), monocyte-to-high density lipoprotein ratio (MHR) and prognostic nutritional index (PNI) in cases with BC treated with NAC.